Implementation and evaluation of Australian pharmacists' diabetes care services

Journal of the American Pharmacists Association : JAPhA
Carol L ArmourInes Krass

Abstract

To implement and evaluate a specialized service for type 2 diabetes mellitus in the community pharmacy. Parallel group, multisite, control versus intervention, repeated measures design, with three different regions in New South Wales, Australia, used as intervention regions, then matched with control regions as much as possible. Following training, pharmacists followed a clinical protocol over 9 months, with approximately monthly intervention site visits during which blood glucose readings were downloaded and discussed with the patient, interventions were documented, and goals set with each patient. Quality of life, well-being, risk of nonadherence, and glycosylated hemoglobin (A1C) values at the beginning and end of the study. Blood glucose levels were measured in intervention patients only. A total of 106 intervention and 82 control patients completed the study. Patient groups were similar at baseline. Pharmacists delivered 1,459 interventions and blood glucose levels were significantly reduced in all intervention regions. The proportion of patients with A1C values greater than 7% was similar in control sites at baseline (54%) and after 9 months (61%). In intervention sites this proportion was significantly reduced, from 72% ...Continue Reading

References

May 1, 1996·Annals of Internal Medicine·R S Epstein, L M Sherwood
Oct 7, 1997·Diabetes Care·A H PaesC J Soe-Agnie
Apr 14, 1999·The Annals of Pharmacotherapy·F VenturiniJ S McCombs
Aug 24, 1999·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·C BradleyR Plowright
Aug 19, 2000·American Journal of Medical Quality : the Official Journal of the American College of Medical Quality·M B DavidsonT L Hair
Feb 15, 2001·JAMA : the Journal of the American Medical Association·E H WagnerL C Grothaus
Apr 12, 2002·Diabetic Medicine : a Journal of the British Diabetic Association·P T DonnanA D Morris
Oct 8, 2003·Patient Education and Counseling·B L SvarstadC Claesson

❮ Previous
Next ❯

Citations

Feb 22, 2012·Perspectives in Clinical Research·R VenkatesanS Sriram
Jun 11, 2009·American Journal of Pharmaceutical Education·Rosemin Kassam, Mona Kwong
Aug 14, 2015·BMJ Open·Yazid N Al HamarnehRoss T Tsuyuki
Mar 18, 2009·Journal of the American Pharmacists Association : JAPhA·Scott V MonteJoseph A Paladino
Feb 26, 2005·Journal of the American Pharmacists Association : JAPhA·Ines KrassCarol L Armour
Feb 2, 2010·Diabetes Research and Clinical Practice·Garry WelchRobert A Gabbay
Mar 17, 2009·Research in Social & Administrative Pharmacy : RSAP·Ines KrassTipaporn Kanjanarach
May 26, 2007·Diabetic Medicine : a Journal of the British Diabetic Association·I KrassJ Wilkinson
Nov 10, 2010·Diabetic Medicine : a Journal of the British Diabetic Association·S A Doggrell
Jan 18, 2011·The International Journal of Pharmacy Practice·Rosalind M DeySinthia Bosnic-Anticevich
Mar 23, 2011·Diabetic Medicine : a Journal of the British Diabetic Association·I KrassC Armour
Oct 2, 2012·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Susanne KaaeLotte S Nørgaard
Jul 6, 2014·The International Journal of Pharmacy Practice·Pradnya Naik-PanvelkarCarol L Armour
Aug 17, 2006·The Annals of Pharmacotherapy·A Simon Pickard, Shih-Ying Hung
Apr 30, 2009·The Annals of Pharmacotherapy·William R DoucetteRandal P McDonough
Jun 22, 2018·The International Journal of Pharmacy Practice·Aleksandra MilosavljevicJeff Harrison
Jun 26, 2007·Pharmacy World & Science : PWS·Els MehuysMimi Giri
May 6, 2010·The Annals of Pharmacotherapy·Elizabeth Manias, Allison Williams
May 9, 2014·International Journal of Clinical Pharmacy·Anan S JarabSharrel Pinto
Dec 7, 2019·The Cochrane Database of Systematic Reviews·Liz SteedR T Walton
Mar 29, 2011·International Journal of Clinical Pharmacy·Susanne KaaeLotte Stig Nørgaard
Jul 31, 2019·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Zheng Kang LumJoyce Yu-Chia Lee
Mar 12, 2011·International Journal of Clinical Pharmacy·Cassyano Januário CorrerRoberto Pontarolo
Feb 20, 2021·Research in Social & Administrative Pharmacy : RSAP·Mariam M BashetiBandana Saini
Jun 10, 2021·Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC·Yazid N Al HamarnehRoss T Tsuyuki

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.